Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Eski who wrote (398)	3/31/1998 8:44:00 PM
From: Aishwarya	Read Replies (2) \| Respond to of 2887

Thanks for the timely long awaited news Hugo. like i said in my previous post earnings were expected to be be just average and the whole of 1997 was a loss. None on the thread expected profits right now. Lets get to the core topic now ? Why did some people get in three weeks back and accumulate heavy positions in the stock. Because they believe in the following : Mr. Rash continued, ''In September, we were recommended for International Standards Organization (ISO) 9001 Certification by the ISO 9001 Registrar, and received Certification early this year. One month after receipt of Certification, we entered into our first original equipment manufacturer (OEM) agreement with Polamedco, Inc., a privately held disposable medical products manufacturer, to manufacture assorted sizes of their nasopharyngeal airway products. We believe ISO 9001 Certification has given American BioMed a competitive advantage, and will certainly allow us to attract additional OEM partnerships and additional business opportunities.'' ''In order to expand the company's international marketing activities, American BioMed submitted documentation to secure the CE Mark, currently required by the European Commission for many products sold in the European marketplace, for certification of product quality for its entire product line,'' added Mr.Rash. Mr. Rash continued, ''During the year, we submitted two 510(k)s to the U.S. Food and Drug Administration (FDA) for market clearance of two new versions of American BioMed's 100%-silicone based balloon catheter products. We received FDA approval for the Ahn thrombectomy catheter in January 1998, marking the company's first internally developed product. Our second internally developed product, a 100% silicone-based bi-lumen balloon catheter utilizing the company's dual balloon technology, is currently pending market clearance and we are working diligently with the FDA to expedite the approval process.'' Here is to the future !!!!! ''1997 was a building year for American BioMed, a year in which we made substantial investments in five key areas to strengthen the company's infrastructure. First, as a result of the consolidation of all of the company's manufacturing operations into our Irvine, California facility in 1996, we were able to increase our manufacturing capabilities and efficiencies in 1997. Second, investments were made in American BioMed's manufacturing activities, resulting in productivity improvements. Third, we invested in product development and clinical investigational programs to further the advancement of our core product technologies. Fourth, we expanded our sales and marketing activities by implementing new marketing programs. Finally, we reshaped our balance sheet and raised additional equity capital to further the company's strategic business plan. These combined initiatives have allowed us to establish a stronger foundation for the future growth of our company, and will allow us to take advantage of the many opportunities in the marketplace for our unique line of medical devices,'' Mr. Rash concluded. Now i know what a lot of folks will think. Bad earnings for the last quarter means everyone will dump. But they could be wrong as the future prospects is what all investors want to evaluate and digest. ABMI has already surpassed its 1st quarter earnings goal for 1998 and a lot of other stuff is in store for this little company with a bright future. If it drops at all, it will only represent an opportunity to accumulate. Regards, Sri.